EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Sialorrhea in patients with ALS: current treatment options

Giancarlo Garuti, Fabrizio Rao, Viviana Ribuffo, Valeria A Sansone

Degenerative Neurological and Neuromuscular Disease · 2019-03 · Volume 9 · 19-26

DOI: 10.2147/dnnd.s168353 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Degenerative Neurological and Neuromuscular Disease, 2019-03. Verfasst von Giancarlo Garuti und 3 weiteren Autor:innen. Beteiligte Einrichtung: Pneumology Unit, Santa Maria Bianca Hospital, Mirandola, AUSL Modena, Modena, Italy. Die Arbeit wurde bisher 21-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder of the motor neuron, which selectively affects it both at central (first motor-neuron) and peripheral level (second motor-neuron). The disease shows up at a mean age of 56 years and the most affected are males. Although ALS may start as a bulbar or spinal disease, with the progression of the disease typically both become evident. Pharmacological approved treatments for ALS are still limited and include riluzole and edaravone which improve survival over time. Despite this, ALS leads to progressive muscle involvement and requires a complex multidisciplinary approach to manage increasing disability which goes beyond motor neurons. Sialorrhea is, amongst others, one of the most disabling symptoms in ALS. The complexity in managing saliva is due to a muscular spasticity and to a scarce palatino-lingual muscles control, rather than to an overproduction of saliva. These features could increase the risk of aspiration pneumonia and limit the use of noninvasive mechanical ventilation. We reviewed the treatment for sialorrhea in ALS patients that are available at this time, emphasizing pros and cons for each approach. Our purpose is to create a practical tool for the diagnosis, in order to facilitate the quantification and management of sialorrhea in everyday practice.

Schlagwörter

Stichwörter der Autor:innen

amyotrophic lateral sclerosisanticholinergic drugbotulinum toxinradiotherapy salivary glandsialorrhea

Autor:innen und Institutionen

  • Pneumology Unit, Santa Maria Bianca Hospital, Mirandola, AUSL Modena, Modena, Italy.
  • Respiratory Unit, Neuromuscular OmniCentre (NeMO), Neurorehabilitation, University of Milan, Niguarda Hospital, Milan, Italy.
  • Neuromuscular Omnicentre (NeMO), Neurorehabilitation, University of Milan, Niguarda Hospital, Milan, Italy.

Zitieren

APA

Garuti, G., Rao, F., Ribuffo, V., & Sansone, V. A. (2019). Sialorrhea in patients with ALS: current treatment options. Degenerative Neurological and Neuromuscular Disease, Volume 9, 19-26. https://doi.org/10.2147/dnnd.s168353

Vancouver

Garuti G, Rao F, Ribuffo V, Sansone VA. Sialorrhea in patients with ALS: current treatment options. Degenerative Neurological and Neuromuscular Disease. 2019;Volume 9:19-26. doi:10.2147/dnnd.s168353

BibTeX
@article{Garuti2019,
  author = {Garuti, Giancarlo and Rao, Fabrizio and Ribuffo, Viviana and Sansone, Valeria A},
  title = {Sialorrhea in patients with ALS: current treatment options},
  journal = {Degenerative Neurological and Neuromuscular Disease},
  year = {2019},
  volume = {Volume 9},
  pages = {19--26},
  doi = {10.2147/dnnd.s168353}
}
Kostenlos starten →